Heartflow (NASDAQ:HTFL) Stock Jumps 6.9% – Time to Buy?

Heartflow, Inc. (NASDAQ:HTFL)’s share price rose 6.9% on Monday. The company traded as high as $51.38 and last traded at $51.6030. Approximately 380,510 shares changed hands during trading, a decline of 76% from the average daily volume of 1,584,559 shares. The stock had previously closed at $48.29.

Analyst Upgrades and Downgrades

HTFL has been the topic of several research reports. Wells Fargo & Company lifted their target price on Heartflow from $37.00 to $39.00 and gave the stock an “overweight” rating in a report on Friday, August 14th. Weiss Ratings raised Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, August 7th. Stifel Nicolaus raised their price target on Heartflow from $40.00 to $45.00 and gave the company a “buy” rating in a report on Friday, August 14th. Canaccord Genuity Group lifted their price objective on Heartflow from $45.00 to $56.00 and gave the stock a “buy” rating in a research note on Tuesday, September 22nd. Finally, UBS Group began coverage on Heartflow in a report on Wednesday, September 9th. They set a “neutral” rating and a $55.00 price objective on the stock. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Heartflow currently has a consensus rating of “Moderate Buy” and an average price target of $48.62.

Heartflow Stock Up 9.0%

The business’s fifty day moving average price is $48.22 and its two-hundred day moving average price is $35.75.

Heartflow (NASDAQ:HTFL) last posted its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.15. The business had revenue of $64.08 million during the quarter. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%. The firm’s revenue for the quarter was up 47.7% on a year-over-year basis. On average, research analysts anticipate that Heartflow, Inc. will post -0.75 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO John Farquhar sold 38,900 shares of the company’s stock in a transaction dated Monday, October 12th. The shares were sold at an average price of $49.57, for a total transaction of $1,928,273.00. Following the transaction, the chief executive officer directly owned 283,014 shares in the company, valued at approximately $14,029,003.98. This represents a 12.08% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 19,682 shares of the stock in a transaction dated Friday, September 18th. The stock was sold at an average price of $50.15, for a total transaction of $987,052.30. Following the completion of the sale, the insider directly owned 79,956 shares in the company, valued at $4,009,793.40. This trade represents a 19.75% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 304,105 shares of company stock worth $14,173,800 over the last three months. 7.70% of the stock is owned by insiders.

Hedge Funds Weigh In On Heartflow

Large investors have recently bought and sold shares of the business. XXEC Inc. purchased a new position in shares of Heartflow in the 2nd quarter valued at approximately $2,524,764,000. BlackRock Inc. acquired a new stake in Heartflow in the 2nd quarter worth approximately $152,502,000. Bamco Inc. NY purchased a new stake in Heartflow during the 2nd quarter worth approximately $94,625,000. Jupiter Topco LLC purchased a new stake in Heartflow during the 2nd quarter worth approximately $70,983,000. Finally, Janus Henderson Group PLC increased its stake in Heartflow by 152.0% during the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock valued at $53,063,000 after purchasing an additional 1,315,416 shares in the last quarter.

Heartflow Company Profile

Heartflow, Inc is a medical technology company that develops artificial intelligence-based tools to help physicians diagnose and manage coronary artery disease. Its platform uses data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient’s coronary arteries and provide noninvasive assessments of blood flow and disease.

The company’s products include Heartflow Analysis, which provides fractional flow reserve computed tomography (FFR-CT) evaluations to help identify potentially significant blockages, as well as tools for assessing coronary plaque and planning treatment.